Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$25.10
-3.07%
Mkt Cap $3.94B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (31 analysts)
$35.50
Range $24.00 – $47.00
Implied Upside
+41.5%
Consensus $35.50 vs current $25.10
NASDAQ·Healthcare·Biotechnology
$25.10
-3.07%
Mkt Cap $3.94B
Buy
5
Hold
0
Sell
0
Price Target (31 analysts)
$35.50
Range $24.00 – $47.00
+41.5%
Consensus $35.50 vs current $25.10